-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Crinetics Pharmaceuticals to Hold

Benzinga·07/08/2026 14:50:06
Listen to the news
TD Cowen analyst Tyler Van Buren downgrades Crinetics Pharmaceuticals (NASDAQ:CRNX) from Buy to Hold.